This company seems to have been delisted
Reason: Acquired by Novo Holdings and Gurnet Point
Last recorded trade on: November 17, 2023
Source: https://www.reuters.com/markets/deals/novo-holdings-closes-462-mln-acquisition-paratek-pharmaceuticals-2023-09-21/
Reason: Acquired by Novo Holdings and Gurnet Point
Last recorded trade on: November 17, 2023
Source: https://www.reuters.com/markets/deals/novo-holdings-closes-462-mln-acquisition-paratek-pharmaceuticals-2023-09-21/
Paratek Pharmaceuticals
PRTK
$3.20
Share price
0.00%
Change (1 day)
22.48%
Change (1 year)
Categories
Revenue for Paratek Pharmaceuticals (PRTK)
Revenue in 2023 (TTM): C$0.22 Billion
According to Paratek Pharmaceuticals
's latest financial reports the company's current revenue (TTM 
) is C$0.24 Billion. In 2022 the company made a revenue of C$0.20 Billion an increase over the revenue in the year 2021 that were of C$0.15 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Paratek Pharmaceuticals from 2004 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | C$0.22 B | 10.72% |
| 2022 | C$0.20 B | 32.74% |
| 2021 | C$0.15 B | 177.8% |
| 2020 | C$55.48 M | 156.8% |
| 2019 | C$21.6 M | -7.33% |
| 2018 | C$23.31 M | 47% |
| 2017 | C$15.86 M | 40600.01% |
| 2016 | C$0.03 M | |
| 2015 | N/A | -100% |
| 2014 | C$5.03 M | 170.95% |
| 2013 | C$1.85 M | -83.04% |
| 2012 | C$10.96 M | -45.27% |
| 2011 | C$20.03 M | 60.33% |
| 2010 | C$12.49 M | 128.02% |
| 2009 | C$5.47 M | -92.57% |
| 2008 | C$73.7 M | |
| 2005 | C$0.06 M | -95.15% |
| 2004 | C$1.34 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | C$36.93 M | -84.66% | 🇺🇸 USA |
 | C$0.23 B | -4.36% | 🇺🇸 USA |
 | C$0.80 B | 233.98% | 🇺🇸 USA |